By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



2800 Plymouth Road
NCRC, Building 26
Ann Arbor  Michigan  48220  U.S.A.
Phone: 734-233-3060 Fax: n/a



Start Up

Company News
Lycera Presents Encouraging Safety Results From Phase I ARGON Study Of LYC-55716 At The European Society For Medical Oncology (ESMO) Congress 9/11/2017 6:41:37 AM
Lycera Announces The Appointment Of Pablo J. Cagnoni, M.D., To The Board Of Directors 3/13/2017 8:44:04 AM
Lycera Announces Initiation Of Phase 1/2a Study ARGON Of Immuno-Oncology Candidate LYC-55716 In Patients With Advanced Solid Tumors 1/4/2017 6:12:40 AM
Lycera Announces Initiation Of Phase 2 UPRISE Clinical Trial Of LYC-30937-EC For Patients With Moderate Psoriasis 12/7/2016 6:23:24 AM
Lycera Announces Appointments Of Leading Experts To Scientific Advisory Board 11/11/2016 11:51:54 AM
Lycera Announces Publication Of Immuno-Oncology Research, Demonstrating Differentiated Mechanism Of RORgamma Agonists 11/4/2016 9:19:21 AM
Lycera Announces Initiation Of Phase 2 Clinical Trial Of LYC-30937-EC In Patients With Ulcerative Colitis 8/22/2016 6:41:46 AM
Lycera Congratulates Dr. Peter L. Toogood For His Receipt Of The 2016 Heroes Of Chemistry Award From The American Chemical Society 8/3/2016 10:01:25 AM
Lycera Announces Progress In Immuno-Oncology Program Presented At The 2016 AACR Annual Meeting 4/19/2016 10:29:28 AM
Lycera Announces Presentations Of Positive Preclinical Results For Lead Candidate LYC-30937 And For Selective Rho Kinase Inhibitor Program At The 11th Congress Of The European Crohn's And Colitis Organization (ECCO) 3/18/2016 6:26:42 AM